Batai Ken, Murphy Adam B, Ruden Maria, Newsome Jennifer, Shah Ebony, Dixon Michael A, Jacobs Elizabeth T, Hollowell Courtney M P, Ahaghotu Chiledum, Kittles Rick A
Division of Urology, Department of Surgery, The University of Arizona College of Medicine, University of Arizona Cancer Center, 1515 N. Campbell Ave, P.O. Box 245024, Tucson, AZ, 85724, USA.
Department of Urology, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Ave, Chicago, IL, 60611, USA.
BMC Cancer. 2017 Jan 19;17(1):64. doi: 10.1186/s12885-017-3060-8.
African Americans have disproportionately higher burden of prostate cancer compared to European Americans. However, the cause of prostate cancer disparities is still unclear. Several roles have been proposed for calcium and vitamin D in prostate cancer pathogenesis and progression, but epidemiologic studies have been conducted mainly in European descent populations. Here we investigated the association of calcium and vitamin D intake with prostate cancer in multiethnic samples.
A total of 1,657 prostate cancer patients who underwent screening and healthy controls (888 African Americans, 620 European Americans, 111 Hispanic Americans, and 38 others) from Chicago, IL and Washington, D.C. were included in this study. Calcium and vitamin D intake were evaluated using food frequency questionnaire. We performed unconditional logistic regression analyses adjusting for relevant variables.
In the pooled data set, high calcium intake was significantly associated with higher odds for aggressive prostate cancer (OR = 1.98, 95% C.I.: 1.01-3.91), while high vitamin D intake was associated with lower odds of aggressive prostate cancer (OR = 0.38, 95% C.I.: 0.18-0.79). In African Americans, the association between high calcium intake and aggressive prostate cancer was statistically significant (OR = 4.28, 95% C.I.: 1.70-10.80). We also observed a strong inverse association between total vitamin D intake and prostate cancer in African Americans (OR = 0.06, 95% C.I.: 0.02-0.54). In European Americas, we did not observe any significant associations between either calcium or vitamin D intake and prostate cancer. In analyses stratifying participants based on Body Mass Index (BMI), we observed a strong positive association between calcium and aggressive prostate cancer and a strong inverse association between vitamin D intake and aggressive prostate cancer among men with low BMI (<27.8 kg/m), but not among men with high BMI (≥27.8 kg/m). Interactions of race and BMI with vitamin D intake were significant (P < 0.05).
Calcium intake was positively associated with aggressive prostate cancer, while vitamin D intake exhibited an inverse relationship. However, these associations varied by race/ethnicity and BMI. The findings from this study may help develop better prostate cancer prevention and management strategies.
与欧裔美国人相比,非裔美国人患前列腺癌的负担 disproportionately 更高。然而,前列腺癌差异的原因仍不清楚。钙和维生素D在前列腺癌发病机制和进展中的作用已被提出,但流行病学研究主要在欧洲血统人群中进行。在此,我们在多民族样本中研究了钙和维生素D摄入量与前列腺癌的关联。
本研究纳入了来自伊利诺伊州芝加哥市和华盛顿特区的1657名接受筛查的前列腺癌患者和健康对照者(888名非裔美国人、620名欧裔美国人、111名西班牙裔美国人及38名其他族裔)。使用食物频率问卷评估钙和维生素D摄入量。我们进行了无条件逻辑回归分析,并对相关变量进行了调整。
在汇总数据集中,高钙摄入量与侵袭性前列腺癌的较高患病几率显著相关(OR = 1.98,95%置信区间:1.01 - 3.91),而高维生素D摄入量与侵袭性前列腺癌的较低患病几率相关(OR = 0.38,95%置信区间:0.18 - 0.79)。在非裔美国人中,高钙摄入量与侵袭性前列腺癌之间的关联具有统计学意义(OR = 4.28,95%置信区间:1.70 - 10.80)。我们还观察到非裔美国人中总维生素D摄入量与前列腺癌之间存在强烈的负相关(OR = 0.06,95%置信区间:0.02 - 0.54)。在欧裔美国人中,我们未观察到钙或维生素D摄入量与前列腺癌之间存在任何显著关联。在根据体重指数(BMI)对参与者进行分层的分析中,我们观察到低BMI(<27.8 kg/m²)男性中钙与侵袭性前列腺癌之间存在强烈的正相关,维生素D摄入量与侵袭性前列腺癌之间存在强烈的负相关,但在高BMI(≥27.8 kg/m²)男性中未观察到这种关联。种族和BMI与维生素D摄入量的交互作用显著(P < 0.05)。
钙摄入量与侵袭性前列腺癌呈正相关,而维生素D摄入量呈负相关。然而,这些关联因种族/族裔和BMI而异。本研究结果可能有助于制定更好的前列腺癌预防和管理策略。